Nektar Therapeutics is transforming its business model, shifting from PEGylation drug delivery to innovative immunotherapy and autoimmune treatments. This strategic evolution marks a new chapter in its biotech journey toward sustainable growth and medical
DuPont leads innovation in advanced materials across semiconductors, safety, mobility, and biotechnology. From Tyvek and Nomex protection to bio-based materials and EV solutions, DuPont drives sustainable growth and technologies shaping a smarter future.